Oragenics Stock Price. Everything You Need To Know About The Oragenics Stock!
Oragenics, Inc. is a biopharmaceutical company headquartered in Tampa, Florida that specializes in developing innovative treatments for infectious diseases and oral mucositis. The company was founded in 1996 and went public on July 9, 2003.
Oragenics has a strong pipeline of product candidates, including NT-CoV2-1, Terra CoV-2, and Antibiotics. NT-CoV2-1 is the company’s lead product, and is an intranasal immunization vaccine candidate designed to prevent COVID-19 and variants of the SARS-CoV-2 virus. Terra CoV-2 is an intramuscular vaccine candidate that utilizes plasmid and adjuvant to provide long-lasting immunity against SARS-CoV-2.
In addition to these vaccine candidates, Oragenics is also developing semi-synthetic lantibiotic analogs that may be effective in treating both systemic Gram-positive multidrug infections and Gram-negative infections. The company’s wholly owned subsidiary, Noachis Terra, Inc., is responsible for the research and development of Terra CoV-2 and NT-CoV2-1 vaccine product candidates.
As an investor, it’s important to keep an eye on companies like Oragenics that are working on innovative treatments for infectious diseases. However, investing in biopharmaceutical companies can be risky, and investors should thoroughly research any potential investments and seek advice from financial professionals before making any decisions.
Oragenics Stock Price. Everything You Need To Know About The Oragenics Stock! performance
- Employees 5
- Company HQ Tampa
- Website https://www.oragenics.com/
- OGEN Asset Type Common Stock
- OGEN Market Capitalization 4.6M
- Earnings Per Share -9.18
- Dividends Per Share None
- Dividend Date 2018-01-22
- Quarterly Earnings Growth 0
Are you interested in investing in the stock market from Malaysia, Thailand, Indonesia, or Vietnam? Look no further! Oragenics is a stock that you should consider adding to your investment portfolio. As a content marketing expert at Zorion, an investment platform, I am here to guide you on how to invest in Oragenics from these countries. Oragenics is a biopharmaceutical company focused on developing antibiotics against infectious diseases. By investing in Oragenics, you can tap into the growing demand for healthcare and biotech solutions, making it an attractive investment opportunity. To invest in Oragenics, you can start by opening an account with Zorion. Once you have your account set up, you can easily explore Oragenics as one of the investment options available. Zorion’s investment insights and recommendations will help you make informed decisions about investing in this stock. Furthermore, Zorion provides resources and educational materials to enhance your investment knowledge. This will enable you to stay updated on Oragenics’ performance, industry trends, and any other relevant information. Investing in Oragenics from Malaysia, Thailand, Indonesia, or Vietnam is now within your reach. Start your investment journey with Zorion and take advantage of the opportunities presented by this promising stock.
